THE CLINICAL EFFICACY OF COMBINATION NEBULIZED ANTICHOLINERGIC AND ADRENERGIC BRONCHODILATORS VS NEBULIZED ADRENERGIC BRONCHODILATOR ALONE IN ACUTE ASTHMA
Jm. Fitzgerald et al., THE CLINICAL EFFICACY OF COMBINATION NEBULIZED ANTICHOLINERGIC AND ADRENERGIC BRONCHODILATORS VS NEBULIZED ADRENERGIC BRONCHODILATOR ALONE IN ACUTE ASTHMA, Chest, 111(2), 1997, pp. 311-315
The role of ipratropium bromide as adjunct therapy to beta-agonists in
acute asthma is uncertain. We therefore decided to compare the use of
3 mg of salbutamol sulfate alone vs 3 mg salbutamol sulfate with 0.5
mg ipratropium bromide in patients with acute asthma, Patients present
ing with acute asthma and an FEV(1) less than 70% predicted were rando
mized to a single combination treatment vs salbutamol alone, All patie
nts received supplemental oxygen and methylprednisolone, 125 mg, IV. B
aseline measurements were repeated at 45 and 90 min and these included
spirometry, oximetry, and vital signs, A total of 952 patients were s
creened of whom 342 patients were deemed eligible and were randomized
in two groups of 171 patients. The mean (SE) age was 30 years (0.9) vs
29 years (0.7), women, 103 (60.2%) vs 110 (64%), 81 (47.4%) never-smo
ked vs 83 (48.5%), and duration of asthma in years 16.0 (0.8) vs 16.6
(0.8) were no different in the combination vs salbutamol alone group,
respectively. Likewise, there was no significant difference in asthma
therapy received in the 24 h prior to presentation; most notably, 151
(88.3%) vs 153 (89.5%) received inhaled beta-agonists in that period.
Baseline FEV(1) was 1.62 L (0.05 L) vs 1.53 L (0.03 L), and median tim
e to treatment being received was no different between both groups, Bo
th treatment arms improved significantly, The increase in FEV(1) in th
e combination group was 0.61 L (0.04 L) and in the salbutamol alone gr
oup was 0.52 L (0.04 L) at 90 min. There was a trend toward greater br
onchodilatation in the combination group, but this did not reach stati
stical significance, Fewer hospitalizations, 5.9% vs 11.2%, occurred i
n the combination group, but this did not reach statistical significan
ce. In, conclusion, this large multicenter study failed to show a sign
ificantly better response to a combination of salbutamol and ipratropi
um bromide vs salbutamol alone.